Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
eMagRes 2016
DOI: 10.1002/9780470034590.emrstm1453
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Lipids by 1 H MRS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 42 publications
0
3
0
Order By: Relevance
“…Notice that the (resummed) behavior ∼ (q 2 /µ 2 ) ξ has been also observed when studying the gfp-dependence of fermion propagators through LKF transformations [40,51]. 5 For related studies in the Coulomb gauge, see [47][48][49][50] Evidently, choosing a 0 = 1 and c 1 ≡ c NI = 0.13 ensures that…”
Section: Gluon Propagatormentioning
confidence: 93%
“…Notice that the (resummed) behavior ∼ (q 2 /µ 2 ) ξ has been also observed when studying the gfp-dependence of fermion propagators through LKF transformations [40,51]. 5 For related studies in the Coulomb gauge, see [47][48][49][50] Evidently, choosing a 0 = 1 and c 1 ≡ c NI = 0.13 ensures that…”
Section: Gluon Propagatormentioning
confidence: 93%
“…Myocardial triglyceride content. Myocardial triglyceride content was measured using cardiac 1 H magnetic resonance spectroscopy as described previously (Szczepaniak & Smith, 2007). In short, a single, spectroscopic volume of interest was positioned over the interventricular septum using end-systolic frames of cardiac short axis and pseudo four-chamber cine images.…”
Section: Measurementsmentioning
confidence: 99%
“…10,11 Proton spectroscopy is another CMR technique that can be used to determine intramyocardial triglyceride (IMTG) content, a measure of altered myocardial bioenergetics and lipotoxicity. [12][13][14] Diffuse myocardial interstitial fibrosis and cardiomyocyte lipotoxicity as measured by MECV and IMTG, respectively, are both considered intermediate HF phenotypes. [15][16][17] Systemic metabolic dysregulation is a major risk factor for HF, one that contributes to altered myocardial energetics.…”
Section: Introductionmentioning
confidence: 99%